{"title":"过敏性哮喘与脑血管意外的关系:过敏性哮喘可增加脑卒中的复发。","authors":"Shi Jinghua, Zhao Gaonian, Jiang Su","doi":"10.5114/ada.2024.145458","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Adult asthma as inflammatory-based disease can be an independent risk factor for stroke.</p><p><strong>Aim: </strong>To evaluate the relationship between adult asthma and cerebrovascular accident.</p><p><strong>Material and methods: </strong>120 patients (asthma stroke, asthma non-stroke, and non-asthma stroke groups) who were matched for age and gender were included in this prospective cohort study to observe pulmonary function changes and recurrence rate of stroke among asthmatic patients during 6-month follow-up after first even after first even stroke.</p><p><strong>Results: </strong>In the asthma stroke group, post stroke forced vital capacity (FVC) (3.04 ±0.13 vs. 2.58 ±0.15, <i>p =</i> 0.006), forced expiratory volume in 1 s (FEV1) (2.68 ±0.15 vs. 2.01 ±0.12, <i>p =</i> 0.02), FEV1/FVC (0.88 ±0.03 vs. 0.77 ±0.02, <i>p =</i> 0.001), maximal inspiratory pressure (MIP) (74.05 ±5.36 vs. 56.57 ±3.83, <i>p =</i> 0.001), maximal expiratory pressure (MEP) (88.30 ±3.65 vs. 71.42 ±3.98, <i>p =</i> 0.001) and 6-minute walk test (6MWT) (446.32 ±47.56 vs. 338.62 ±28.85, <i>p =</i> 0.001) were significantly decreased in comparison to before stroke. Also, stroke recurrence was 32.5% in the asthma stroke group and 12.5% in the non-asthma stroke group, which was significantly higher in the asthma stroke group (<i>p =</i> 0.001). Comparison of pulmonary function showed that all FVC (2.58 ±0.15 vs. 3.36 ±0.14, <i>p =</i> 0.001), FEV1 (2.01 ±0.12 vs. 2.73 ±0.16, <i>p =</i> 0.001), FEV1/FVC (0.77 ±0.02 vs. 0.81 ±0.03, <i>p =</i> 0.001), MIP (56.57 ±3.83 vs. 70.62 ±2.77, <i>p =</i> 0.001), MEP (71.42 ±3.98 vs. 85.97 ±2.31, <i>p =</i> 0.001) and 6MWT (338.62 ±28.85 vs. 385.67 ±29.82, <i>p =</i> 0.001) in the asthma stroke group were significantly decreased in comparison to the non-asthma stroke group.</p><p><strong>Conclusions: </strong>FVC, FEV1, FEV1/FVC, MIP, MEP and 6MWT were significantly decreased in allergic asthma patients after stroke, also adult asthma can increase the risk of recurrence of risk of stroke in asthmatic stroke patients.</p>","PeriodicalId":54595,"journal":{"name":"Postepy Dermatologii I Alergologii","volume":"42 2","pages":"150-155"},"PeriodicalIF":1.4000,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12163955/pdf/","citationCount":"0","resultStr":"{\"title\":\"Relationship between allergic asthma and cerebrovascular accident: allergic asthma can increase recurrence of stroke.\",\"authors\":\"Shi Jinghua, Zhao Gaonian, Jiang Su\",\"doi\":\"10.5114/ada.2024.145458\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Adult asthma as inflammatory-based disease can be an independent risk factor for stroke.</p><p><strong>Aim: </strong>To evaluate the relationship between adult asthma and cerebrovascular accident.</p><p><strong>Material and methods: </strong>120 patients (asthma stroke, asthma non-stroke, and non-asthma stroke groups) who were matched for age and gender were included in this prospective cohort study to observe pulmonary function changes and recurrence rate of stroke among asthmatic patients during 6-month follow-up after first even after first even stroke.</p><p><strong>Results: </strong>In the asthma stroke group, post stroke forced vital capacity (FVC) (3.04 ±0.13 vs. 2.58 ±0.15, <i>p =</i> 0.006), forced expiratory volume in 1 s (FEV1) (2.68 ±0.15 vs. 2.01 ±0.12, <i>p =</i> 0.02), FEV1/FVC (0.88 ±0.03 vs. 0.77 ±0.02, <i>p =</i> 0.001), maximal inspiratory pressure (MIP) (74.05 ±5.36 vs. 56.57 ±3.83, <i>p =</i> 0.001), maximal expiratory pressure (MEP) (88.30 ±3.65 vs. 71.42 ±3.98, <i>p =</i> 0.001) and 6-minute walk test (6MWT) (446.32 ±47.56 vs. 338.62 ±28.85, <i>p =</i> 0.001) were significantly decreased in comparison to before stroke. Also, stroke recurrence was 32.5% in the asthma stroke group and 12.5% in the non-asthma stroke group, which was significantly higher in the asthma stroke group (<i>p =</i> 0.001). Comparison of pulmonary function showed that all FVC (2.58 ±0.15 vs. 3.36 ±0.14, <i>p =</i> 0.001), FEV1 (2.01 ±0.12 vs. 2.73 ±0.16, <i>p =</i> 0.001), FEV1/FVC (0.77 ±0.02 vs. 0.81 ±0.03, <i>p =</i> 0.001), MIP (56.57 ±3.83 vs. 70.62 ±2.77, <i>p =</i> 0.001), MEP (71.42 ±3.98 vs. 85.97 ±2.31, <i>p =</i> 0.001) and 6MWT (338.62 ±28.85 vs. 385.67 ±29.82, <i>p =</i> 0.001) in the asthma stroke group were significantly decreased in comparison to the non-asthma stroke group.</p><p><strong>Conclusions: </strong>FVC, FEV1, FEV1/FVC, MIP, MEP and 6MWT were significantly decreased in allergic asthma patients after stroke, also adult asthma can increase the risk of recurrence of risk of stroke in asthmatic stroke patients.</p>\",\"PeriodicalId\":54595,\"journal\":{\"name\":\"Postepy Dermatologii I Alergologii\",\"volume\":\"42 2\",\"pages\":\"150-155\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2024-12-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12163955/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Postepy Dermatologii I Alergologii\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5114/ada.2024.145458\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Postepy Dermatologii I Alergologii","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5114/ada.2024.145458","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
摘要
成人哮喘作为炎症性疾病可能是卒中的独立危险因素。目的:探讨成人哮喘与脑血管意外的关系。材料与方法:本前瞻性队列研究纳入年龄、性别匹配的哮喘卒中、哮喘非卒中、非哮喘卒中组120例患者,观察哮喘患者首次均匀卒中后6个月随访期间肺功能变化及卒中复发率。结果:在哮喘卒中组,卒中后用力肺活量(FVC)(3.04±0.13 vs. 2.58±0.15,p = 0.006)、1 s用力呼气量(FEV1)(2.68±0.15 vs. 2.01±0.12,p = 0.02)、FEV1/FVC(0.88±0.03 vs. 0.77±0.02,p = 0.001)、最大吸气压力(MIP)(74.05±5.36 vs. 56.57±3.83,p = 0.001)、最大呼气压力(MEP)(88.30±3.65 vs. 71.42±3.98,p = 0.001)、6分钟步行测试(6MWT)(446.32±47.56 vs. 338.62±28.85,p = 0.001)。P = 0.001)与卒中前相比显著降低。哮喘卒中组卒中复发率为32.5%,非哮喘卒中组卒中复发率为12.5%,哮喘卒中组卒中复发率明显高于非哮喘卒中组(p = 0.001)。肺功能比较显示,哮喘卒中组的FVC(2.58±0.15 vs. 3.36±0.14,p = 0.001)、FEV1(2.01±0.12 vs. 2.73±0.16,p = 0.001)、FEV1/FVC(0.77±0.02 vs. 0.81±0.03,p = 0.001)、MIP(56.57±3.83 vs. 70.62±2.77,p = 0.001)、MEP(71.42±3.98 vs. 85.97±2.31,p = 0.001)、6MWT(338.62±28.85 vs. 385.67±29.82,p = 0.001)均较非哮喘卒中组显著降低。结论:变应性哮喘患者脑卒中后FVC、FEV1、FEV1/FVC、MIP、MEP、6MWT均显著降低,成人哮喘可增加哮喘性脑卒中患者脑卒中复发风险。
Relationship between allergic asthma and cerebrovascular accident: allergic asthma can increase recurrence of stroke.
Introduction: Adult asthma as inflammatory-based disease can be an independent risk factor for stroke.
Aim: To evaluate the relationship between adult asthma and cerebrovascular accident.
Material and methods: 120 patients (asthma stroke, asthma non-stroke, and non-asthma stroke groups) who were matched for age and gender were included in this prospective cohort study to observe pulmonary function changes and recurrence rate of stroke among asthmatic patients during 6-month follow-up after first even after first even stroke.
Results: In the asthma stroke group, post stroke forced vital capacity (FVC) (3.04 ±0.13 vs. 2.58 ±0.15, p = 0.006), forced expiratory volume in 1 s (FEV1) (2.68 ±0.15 vs. 2.01 ±0.12, p = 0.02), FEV1/FVC (0.88 ±0.03 vs. 0.77 ±0.02, p = 0.001), maximal inspiratory pressure (MIP) (74.05 ±5.36 vs. 56.57 ±3.83, p = 0.001), maximal expiratory pressure (MEP) (88.30 ±3.65 vs. 71.42 ±3.98, p = 0.001) and 6-minute walk test (6MWT) (446.32 ±47.56 vs. 338.62 ±28.85, p = 0.001) were significantly decreased in comparison to before stroke. Also, stroke recurrence was 32.5% in the asthma stroke group and 12.5% in the non-asthma stroke group, which was significantly higher in the asthma stroke group (p = 0.001). Comparison of pulmonary function showed that all FVC (2.58 ±0.15 vs. 3.36 ±0.14, p = 0.001), FEV1 (2.01 ±0.12 vs. 2.73 ±0.16, p = 0.001), FEV1/FVC (0.77 ±0.02 vs. 0.81 ±0.03, p = 0.001), MIP (56.57 ±3.83 vs. 70.62 ±2.77, p = 0.001), MEP (71.42 ±3.98 vs. 85.97 ±2.31, p = 0.001) and 6MWT (338.62 ±28.85 vs. 385.67 ±29.82, p = 0.001) in the asthma stroke group were significantly decreased in comparison to the non-asthma stroke group.
Conclusions: FVC, FEV1, FEV1/FVC, MIP, MEP and 6MWT were significantly decreased in allergic asthma patients after stroke, also adult asthma can increase the risk of recurrence of risk of stroke in asthmatic stroke patients.